Article Versions Notes

Bębenek W, Gajek A, Marczak A, Malý J, Smejkal J, Statkiewicz M, Rusetska N, Bryś M, Rogalska A. MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model. International Journal of Molecular Sciences. 2025; 26(2):834. https://doi.org/10.3390/ijms26020834

Bębenek, Wiktoria, Arkadiusz Gajek, Agnieszka Marczak, Jan Malý, Jiří Smejkal, Małgorzata Statkiewicz, Natalia Rusetska, Magdalena Bryś, and Aneta Rogalska. 2025. "MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model" International Journal of Molecular Sciences 26, no. 2: 834. https://doi.org/10.3390/ijms26020834

Bębenek, W., Gajek, A., Marczak, A., Malý, J., Smejkal, J., Statkiewicz, M., Rusetska, N., Bryś, M., & Rogalska, A. (2025). MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model. International Journal of Molecular Sciences, 26(2), 834. https://doi.org/10.3390/ijms26020834